- Consolidated revenues for 2015
increased 8% to $37.9 billion
- Adjusted income from
operations1 for 2015 was $2.3 billion, or $8.66 per
share, with per share growth of 10% over 2014
- Shareholders’ net income for 2015
was $2.1 billion, or $8.04 per share
- Consolidated revenues and adjusted
income from operations1,2 are expected to grow in
2016
Cigna Corporation (NYSE: CI) today reported strong fourth
quarter and full year 2015 results with revenue and earnings
contributions across the Company’s diversified portfolio of
businesses driven by the continued effective execution of our
strategy. Consolidated revenues for 2015 were $37.9 billion, an
increase of 8% over 2014.
Cigna's adjusted income from operations1 for full year 2015 was
$2.3 billion, or $8.66 per share, compared with $2.1 billion, or
$7.87 per share, for 2014. This represents per share growth of 10%
and reflects strong revenue growth and continued favorable medical
and operating costs in the Global Health Care segment. For the
fourth quarter of 2015, adjusted income from operations1 was $486
million, or $1.87 per share, compared to $475 million, or $1.80 per
share, for the fourth quarter of 2014.
“The strong results we delivered in 2015 reflect our proven
ability to create sustained value for customers and clients,” said
David M. Cordani, President and Chief Executive Officer. “The
effective execution of our global strategy and our differentiated
capabilities provide us with strong momentum as we begin 2016. Our
pending combination with Anthem will further accelerate our
strategy to improve quality, choice, and affordability in the
marketplace.”
Cigna also reported shareholders’ net income in 2015 of $2.1
billion, or $8.04 per share, compared to $2.1 billion, or $7.83 per
share, for 2014. Shareholders’ net income for 2015 included special
items1, which resulted in after-tax charges of $122 million, or
$0.47 per share, for costs associated with the early redemption of
long term debt as well as transaction costs related to Cigna’s
proposed merger with Anthem.
For the fourth quarter of 2015, shareholders’ net income was
$426 million, or $1.64 per share, compared with $467 million, or
$1.77 per share, for the fourth quarter of 2014. Fourth quarter
2015 shareholders’ net income included a special item1 charge of
$28 million after-tax, or $0.11 per share, for transaction costs
related to Cigna’s proposed merger with Anthem.
CONSOLIDATED HIGHLIGHTS
The following table includes highlights of results and a
reconciliation of adjusted income from operations1 to shareholders’
net income:
Consolidated Financial Results (dollars in millions,
customers in thousands):
Year
Three Months Ended Ended
December 31,
September 30,
December 31, 2015 2014
2015 2015 Consolidated Revenues $ 9,528
$ 8,928 $ 9,389 $ 37,876
Consolidated Earnings, net of
taxes Adjusted income from operations1 $ 486 $ 475 $ 593 $
2,256 Net realized investment gains (losses) (28) 21 7 40
Amortization of other acquired intangible assets, net1 (4) (29)
(24) (80) Special items1 (28) -
(29) (122) Shareholders' net income $ 426 $
467 $ 547 $ 2,094 Adjusted income from
operations1, per share $ 1.87 $ 1.80 $ 2.28 $
8.66 Shareholders' net income, per share $ 1.64 $ 1.77
$ 2.10 $ 8.04
As of the Periods Ended
December 31,
September 30,
2015 2014 2015 Global
Medical Customers 14,999 14,456 14,849
- Cash and marketable investments at the
parent company were approximately $1.4 billion at December 31, 2015
and approximately $400 million at December 31, 2014.
- In 2015, the Company repurchased
approximately 5.5 million shares of stock for approximately $685
million. During the period January 1, 2016 through February 3,
2016, the Company repurchased an additional 785,000 shares of
common stock for approximately $110 million.3
- Given the pending combination with
Anthem, it is unlikely that the Company will make further share
repurchases in 2016.
HIGHLIGHTS OF SEGMENT RESULTS
See Exhibit 2 for a reconciliation of adjusted income (loss)
from operations1 to shareholders’ net income.
Global Health
Care
This segment includes Cigna’s Commercial and Government
businesses that deliver medical and specialty health care products
and services to domestic and multi-national clients and customers
using guaranteed cost, retrospectively experience-rated and
administrative services only (“ASO”) funding arrangements.
Specialty health care includes behavioral, dental, disease and
medical management, stop loss and pharmacy-related products and
services.
Financial Results (dollars in millions, customers in
thousands): Year Three Months
Ended Ended December 31, September
30, December 31, 2015 2014
2015 2015 Premiums and Fees $ 6,721 $
6,254 $ 6,619 $ 26,803 Adjusted Income from Operations1 $ 394 $ 397
$ 482 $ 1,848 Adjusted Margin, After-Tax5 5.2% 5.7% 6.5% 6.2%
As of the Periods Ended December 31,
September 30,
Customers:
2015 2014 2015 Commercial 14,432
13,938 14,291 Government 567 518
558 Medical 14,999 14,456 14,849 Behavioral Care 24,674
23,853 24,591 Dental4 13,869 13,571 13,872 Pharmacy 8,068 7,542
7,980 Medicare Part D 1,476 1,188 1,472
- Global Health Care delivered another
strong result in 2015, reflecting consistent strong performance in
our well-positioned growth businesses.
- Full year 2015 premiums and fees grew
10% to $26.8 billion reflecting ongoing growth in our self-funded
programs, specialty products, and Government businesses.
- Cigna’s medical customer base grew
543,000, or 4%, in 2015 to a total of 15 million customers, driven
by organic growth in our Middle Market, International, Select, and
Medicare segments as well as the impact of our acquisition of
Qualcare Alliance Networks.
- Full year adjusted income from
operations1 reflects business growth, including specialty
contributions, and continued favorable medical costs in our
Commercial employer business.
- Fourth quarter 2015 adjusted income
from operations1 and adjusted margin, after-tax5 reflect strong
contributions from our Commercial employer and specialty
businesses, as well as unfavorable medical costs in our Individual
and Government businesses. The decline in fourth quarter 2015
relative to the third quarter 2015 is primarily driven by the
seasonal impact of medical costs as well as higher spending on
strategic initiatives.
- Adjusted income from operations1
included favorable prior year reserve development on an after-tax
basis of approximately $60 million for full year 2015 compared to
$53 million for full year 2014.
- For full year 2015, Cigna has recorded
receivables of approximately $250 million, after-tax related to
2015 risk mitigation programs with approximately 40% of the total
related to reinsurance and the remainder split fairly evenly
between risk adjustment and risk corridor.
- The Total Commercial medical care
ratio9 (MCR) of 78.1% for the full year 2015, and 80.4% in fourth
quarter 2015, reflect the ongoing strong performance of our
Commercial employer business as well as continued high medical
costs in our U.S. Individual business. The fourth quarter MCR also
reflects expected higher seasonal medical costs.
- The Total Government MCR9 of 85.2% for
the full year 2015, and 83.1% in fourth quarter 2015, reflect the
ongoing strong performance in our Medicare Advantage business,
partially offset by pressure in our Medicare Part D business.
Fourth quarter Medicare Advantage results also include some
unfavorable medical cost variability in a specific market.
- Full year medical cost trend for our
total U.S. Commercial book of business was approximately 5% and
reflects continued favorable medical costs, physician engagement
and low utilization trend.
- The 2015 Global Health Care operating
expense ratio9 of 21.4%, and the fourth quarter 2015 ratio of
22.7%, reflect ongoing efficiency gains, offset by continued
investments in strategic initiatives and higher non-recurring
expenses in the fourth quarter.
- Global Health Care net medical costs
payable6 was approximately $2.11 billion at December 31, 2015 and
$1.93 billion at December 31, 2014.
Global Supplemental
Benefits
This segment includes Cigna’s global individual supplemental
health, life and accident insurance business, primarily in Asia,
and Medicare supplement coverage in the United States.
Financial Results (dollars in millions,
policies in thousands):
Year Three Months Ended Ended
December 31, September 30, December 31,
2015 2014 2015
2015 Premiums and Fees7 $ 776 $ 726 $ 761 $ 3,021
Adjusted Income from Operations1 $ 54 $ 36 $ 62 $ 262 Adjusted
Margin, After-Tax5 6.7% 4.8% 7.8% 8.3%
As of the Periods
Ended December 31, September 30, 2015
2014 2015 Policies7 12,888
12,342 12,808
- Global Supplemental Benefits delivered
attractive growth and profitability in 2015 on a currency adjusted
basis as we continue to provide value to individual consumers with
affordable and personalized solutions on a direct basis.
- Excluding the impact of foreign
currency movements, 2015 premiums and fees grew 12% in Global
Supplemental, reflecting ongoing customer growth in Cigna's target
markets and strong retention.
- Full year 2015 adjusted income from
operations1 and adjusted margin, after-tax5 reflect business growth
and favorable claims experience in Korea partially offset by the
impact of foreign currency movements.
- Fourth quarter 2015 adjusted income
from operations1 and adjusted margin, after-tax5 reflect favorable
claims experience in Korea and business growth.
- Foreign currency movements adversely
impacted full year 2015 adjusted income from operations1 by $26
million after-tax8.
Group Disability and
Life
This segment includes Cigna’s group disability, life and
accident insurance operations.
Financial Results (dollars in
millions):
Year Three Months Ended Ended
December 31, September 30, December 31,
2015 2014 2015
2015 Premiums and Fees $ 998 $ 920 $ 980 $ 3,932
Adjusted Income from Operations1 $ 83 $ 85 $ 84 $ 324 Adjusted
Margin, After-Tax5 7.6% 8.4% 7.9% 7.6%
- Group Disability and Life results
continue to reflect the value created for our customers by our
differentiated productivity and return to work programs.
- Full year 2015 premiums and fees
increased 8% over 2014 driven by business growth across the
disability, life and accident product lines.
- Adjusted income from operations1 and
adjusted margin, after-tax5 for full year 2015 reflect continued
strong results, including an improvement in claims experience in
our life business.
- Third quarter 2015 adjusted income from
operations1 and adjusted margin, after-tax5 includes the favorable
after-tax impact related to reserve studies of $11 million.
Corporate & Other
Operations
Adjusted income (loss) from operations1 for Cigna's remaining
operations is presented below:
Financial Results (dollars in
millions):
Year Three Months Ended
Ended December 31, September 30,
December 31, 2015 2014
2015 2015 Corporate & Other
Operations $ (45) $ (43) $ (35) $ (178)
- Third quarter 2015 adjusted income from
operations1 benefited from lower corporate expenses.
2016 OUTLOOK
Cigna's outlook for full year 2016 consolidated adjusted income
from operations1, 2 is in the range of $8.85 to $9.25 per share.
This outlook excludes the impact of prior year reserve development
and the potential effects of future capital deployment.3
Full-Year
Ending
Projected 2016
Growth in:
December 31,
2016
Consolidated Revenue Mid-single digit percentage
range
Consolidated Adjusted Income (Loss) from
Operations1,2,11 High single digit percentage range
Global Medical Customers10 Low single digit
percentage range
Consolidated Adjusted
Income (Loss) from Operations, per share1,2,3
$8.85 to 9.25
Effective January 21, 2016, the Centers for Medicare &
Medicaid Services (“CMS”) imposed sanctions suspending Cigna's
enrollment and marketing activities related to all Cigna Medicare
Advantage and standalone prescription drug plan contracts. The
suspension does not impact current Cigna Medicare Advantage and
Medicare Part D enrollees’ benefits or plans. Cigna is committed to
ensuring that its customers have access to the quality healthcare,
customer service and prescription drugs that they need and is
working to resolve these matters as quickly as possible in full
cooperation with CMS. The expected impact from these sanctions is
reflected in Cigna's 2016 outlook for growth in revenue, adjusted
income from operations1,2, adjusted income from operations per
share1,2, and global medical customers.
The foregoing statements represent the Company’s current
estimates of Cigna's 2016 consolidated and segment adjusted income
from operations1,2 and other key metrics as of the date of this
release. Actual results may differ materially depending on a number
of factors. Investors are urged to read the Cautionary Note
Regarding Forward-Looking Statements included in this release.
Management does not assume any obligation to update these
estimates.
This quarterly earnings release and the Quarterly Financial
Supplement are available on Cigna’s website in the Investor
Relations section (http://www.cigna.com/aboutcigna/investors).
Notes:
1.
Effective January 1, 2015, adjusted
income (loss) from operations is defined as shareholders’ net
income (loss) excluding the following after-tax adjustments: net
realized investment results, net amortization of other acquired
intangible assets and special items. Prior year amounts have been
adjusted for the exclusion of net amortization of other acquired
intangible assets. Net amortization of other acquired intangible
assets in 2015 includes the after-tax impact of $23 million from
the one-time benefit of an acquisition in which the fair value of
acquired net assets exceeded the purchase price. Special items are
identified in Exhibit 2 of this earnings release.
Adjusted income (loss) from operations
is a measure of profitability used by Cigna’s management because it
presents the underlying results of operations of Cigna’s businesses
and permits analysis of trends in underlying revenue, expenses and
shareholders’ net income. This consolidated measure is not
determined in accordance with accounting principles generally
accepted in the United States of America (GAAP) and should not be
viewed as a substitute for the most directly comparable GAAP
measure, shareholders’ net income. See Exhibit 2 for a
reconciliation of adjusted income from operations to shareholders’
net income.
2.
Management is unable to provide a
forward-looking reconciliation of adjusted income (loss) from
operations to shareholders’ net income for full year 2016 because
future net realized investment results, net amortization of other
acquired intangible assets and special items cannot be identified
or reasonably estimated at this time.
3.
The Company’s outlook excludes the
potential effects of any share repurchases or business combinations
that may occur after the date of this earnings release.
4.
Prior period dental customers have been
revised to conform to current presentation.
5.
Adjusted margin, after-tax, is
calculated by dividing adjusted income (loss) from operations by
operating revenues for each segment.
6.
Global Health Care medical costs
payable are presented net of reinsurance and other recoverables.
The gross Global Health Care medical costs payable balance was
$2.36 billion as of December 31, 2015 and $2.18 billion as of
December 31, 2014.
7.
Cigna owns a 50% noncontrolling
interest in its China joint venture. Cigna's 50% share of the joint
venture’s earnings is reported in Other Revenues using the equity
method of accounting under GAAP. As such, the premiums and fees and
policy counts for the Global Supplemental Benefits segment do not
include the China joint venture.
8.
Impact of foreign currency movements
was determined by applying actual 2015 currency exchange rates to
results for the full year 2014.
9.
Operating ratios are defined as
follows:
•
Total Commercial medical care ratio
represents medical costs as a percentage of premiums for all
commercial risk products, including medical, pharmacy, dental, stop
loss and behavioral products provided through guaranteed cost or
experience-rated funding arrangements in both the United States and
internationally.
•
Total Government medical care ratio
represents medical costs as a percentage of premiums for Medicare
Advantage, Medicare Part D, and Medicaid products.
•
Global Health Care Operating Expense
Ratio represents operating expenses excluding acquisition related
amortization expense as a percentage of operating revenue in the
Global Health Care segment.
10.
Global medical customers include
individuals who meet any one of the following criteria: are covered
under a medical insurance policy, managed care arrangement, or
service agreement issued by Cigna; have access to Cigna's provider
network for covered services under their medical plan; or have
medical claims and services that are administered by Cigna.
11.
The percentage growth projected in 2016
for Consolidated Adjusted Income (Loss) from Operations reflects an
increase over such metric for 2015, excluding prior year reserve
development of $60 million after-tax recognized in 2015.
NOTE REGARDING FORWARD-LOOKING
STATEMENTS
This press release, and oral statements made with respect to
information contained in this release, may contain forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995. Forward-looking statements are based on Cigna's
current expectations and projections about future trends, events
and uncertainties. These statements are not historical facts.
Forward-looking statements may include, among others, statements
concerning our projected consolidated adjusted income (loss) from
operations outlook for 2016; projected consolidated revenue growth
and global medical customer growth, each over year end 2015; future
financial or operating performance, including our ability to
deliver personalized and innovative solutions for our customers and
clients and future growth, business strategy, strategic or
operational initiatives; economic, regulatory or competitive
environments, particularly with respect to the pace and extent of
change in these areas; financing or capital deployment plans; our
prospects for growth in the coming years; statements regarding the
proposed merger between Cigna and Anthem, Inc. (Anthem); statements
regarding the timing of resolution of the issues raised by CMS; and
other statements regarding Cigna’s and Anthem’s future beliefs,
expectations, plans intentions, financial condition or performance.
You may identify forward-looking statements by the use of words
such as “believe,” “expect,” “plan,” “intend,” “anticipate,”
“estimate,” “predict,” “potential,” “may,” “should,” “will” or
other words or expressions of similar meaning, although not all
forward-looking statements contain such terms.
Forward-looking statements are subject to risks and
uncertainties, both known and unknown, that could cause actual
results to differ materially from those expressed or implied in
forward-looking statements. Such risks and uncertainties include,
but are not limited to: our ability to achieve our financial,
strategic and operational plans or initiatives; our ability to
predict and manage medical costs and price effectively and develop
and maintain good relationships with physicians, hospitals and
other health care providers; our ability to identify potential
strategic acquisitions or transactions and realize the expected
benefits of such transactions; the substantial level of government
regulation over our business and the potential effects of new laws
or regulations, or changes in existing laws or regulations; the
outcome of litigation, regulatory audits, including the CMS review
and sanctions, investigations and actions and/or guaranty fund
assessments; uncertainties surrounding participation in
government-sponsored programs such as Medicare; the effectiveness
and security of our information technology and other business
systems; and unfavorable industry, economic or political
conditions, including foreign currency movements; the timing and
likelihood of completion of the proposed merger, including the
timing, receipt and terms and conditions of any required
governmental and regulatory approvals for the proposed merger that
could reduce anticipated benefits or cause the parties to abandon
the transaction; the possibility that the expected synergies and
value creation from the proposed merger will not be realized or
will not be realized within the expected time period; the risk that
the businesses of Cigna and Anthem will not be integrated
successfully; disruption from the proposed merger making it more
difficult to maintain business and operational relationships; the
risk that unexpected costs will be incurred; the possibility that
the proposed merger does not close, including due to the failure to
satisfy the closing conditions; the risk that financing for the
proposed merger may not be available on favorable terms, as well as
more specific risks and uncertainties discussed in our most recent
report on Form 10-K and subsequent reports on Forms 10-Q and 8-K
available on the Investor Relations section of www.cigna.com as
well as on Anthem’s most recent report on Form 10-K and subsequent
reports on Forms 10-Q and 8-K available on the Investor Relations
section of www.antheminc.com. You should not place undue reliance
on forward-looking statements, which speak only as of the date they
are made, are not guarantees of future performance or results, and
are subject to risks, uncertainties and assumptions that are
difficult to predict or quantify. Cigna undertakes no obligation to
update or revise any forward-looking statement, whether as a result
of new information, future events or otherwise, except as may be
required by law.
CIGNA CORPORATION
COMPARATIVE SUMMARY OF FINANCIAL
RESULTS (unaudited)
Exhibit 1
(Dollars in millions, except per share
amounts)
Three Months Ended
Year Ended December 31, December 31,
2015 2014 2015
2014 REVENUES Premiums $ 7,461 $
6,906 $ 29,642 $ 27,214 Fees 1,056 1,021 4,217 3,880 Net investment
income 295 303 1,153 1,166 Mail order pharmacy revenues 690 614
2,536 2,239 Other revenues 73 60 271
261 Total operating revenues 9,575 8,904 37,819 34,760 Net realized
investment gains (losses) (47) 24 57 154
Total $ 9,528
$ 8,928 $ 37,876 $ 34,914
ADJUSTED
INCOME (LOSS) FROM OPERATIONS (1) Global Health Care $
394 $ 397 $ 1,848 $ 1,752 Global Supplemental Benefits 54 36 262
243 Group Disability and Life 83 85 324
317 Ongoing Operations 531 518 2,434 2,312 Corporate and Other (45)
(43) (178) (197)
Total $ 486 $ 475 $ 2,256 $ 2,115 After-tax
adjustments to reconcile to shareholders' net income: Realized
investment gains (losses) (28) 21 40 106 Amortization of other
acquired intangible assets, net (4) (29) (80) (119) Special items
(28) - (122) -
Shareholders' net income $ 426 $ 467
$ 2,094 $ 2,102
DILUTED EARNINGS PER
SHARE Adjusted income from operations (1) $ 1.87 $ 1.80
$ 8.66 $ 7.87 After-tax adjustments to reconcile to shareholders'
net income: Realized investment gains (losses) (0.11) 0.08 0.15
0.40 Amortization of other acquired intangible assets, net (0.01)
(0.11) (0.30) (0.44) Special items (0.11)
- (0.47) - Shareholders' net
income $ 1.64 $ 1.77 $ 8.04 $ 7.83
Weighted average shares (in thousands) 260,518
264,284 260,592 268,603 Common
shares outstanding (in thousands)
256,544 259,276
SHAREHOLDERS'
EQUITY at December 31, $
12,035 $ 10,774
SHAREHOLDERS' EQUITY PER SHARE at
December 31, $ 46.91
$ 41.55
(1) Adjusted income (loss) from operations
is defined as shareholders' net income (loss) excluding the
following after-tax adjustments: realized investment results; net
amortization of other acquired intangible assets; and special items
(identified and quantified on Exhibit 2).
CIGNA CORPORATION
RECONCILIATION OF ADJUSTED INCOME (LOSS) FROM OPERATIONS TO
SHAREHOLDERS' NET INCOME Exhibit 2 (Dollars in
millions, except per share amounts)
Diluted
Global Group Corporate
Earnings Global Supplemental
Disability and Per Share Consolidated
Health Care Benefits and Life Other
Three Months Ended December 31, 4Q15
4Q14 3Q15 4Q15
4Q14 3Q15 4Q15
4Q14 3Q15 4Q15
4Q14 3Q15 4Q15
4Q14 3Q15 4Q15
4Q14 3Q15
Adjusted income
(loss) from operations $ 1.87 $ 1.80 $ 2.28 $ 486 $ 475 $ 593 $ 394
$ 397 $ 482 $ 54 $ 36 $ 62 $ 83 $ 85 $ 84 $ (45) $ (43) $ (35)
After-tax adjustments to reconcile to shareholders' net income:
Realized investment gains (losses) (0.11) 0.08 0.02 (28) 21 7 (20)
14 14 2 3 (1) (9) (1) (6) (1) 5 - Amortization of other acquired
intangible assets, net (0.01) (0.11) (0.09) (4) (29) (24) (20) (26)
(21) 16 (3) (3) - - - - - - Special items: Merger-related
transaction costs (0.11) -
(0.11) (28) - (29)
- - - -
- - - -
- (28) - (29)
Shareholders' net income $ 1.64 $ 1.77 $ 2.10
$ 426 $ 467 $ 547 $ 354 $ 385 $
475 $ 72 $ 36 $ 58 $ 74 $ 84
$ 78 $ (74) $ (38) $ (64) Weighted
average shares (in thousands) Special Items, pre-tax: 260,518
264,284 260,519 Merger-related transaction costs $ (31) $ -
$ (35) $ - $ - $ - $ - $
- $ - $ - $ - $ - $ (31)
$ - $ (35) Total $ (31) $ - $ (35) $ -
$ - $ - $ - $ - $ - $ -
$ - $ - $ (31) $ - $ (35)
Diluted Global Group Corporate
Earnings Global Supplemental Disability
and Per Share Consolidated Health Care
Benefits and Life Other Year Ended December
31, 2015 2014
2015 2014 2015
2014 2015
2014 2015
2014 2015 2014
Adjusted income (loss) from operations $ 8.66 $ 7.87 $ 2,256
$ 2,115 $ 1,848 $ 1,752 $ 262 $ 243 $ 324 $ 317 $ (178) $ (197)
After-tax adjustments to reconcile to shareholders' net income:
Realized investment gains (losses) 0.15 0.40 40 106 30 54 1 3 4 14
5 35 Amortization of other acquired intangible assets, net (0.30)
(0.44) (80) (119) (84) (106) 4 (13) - - - - Special items: Debt
extinguishment costs (0.25) - (65) - - - - - - - (65) -
Merger-related transaction costs (0.22)
- (57) -
- - -
- -
- (57) - Shareholders'
net income $ 8.04 $ 7.83 $ 2,094
$ 2,102 $ 1,794 $ 1,700
$ 267 $ 233 $ 328
$ 331 $ (295) $ (162) Weighted
average shares (in thousands) 260,592 268,603 Common shares
outstanding as of December 31, (in thousands) 256,544 259,276
Special Items, pre-tax: Debt extinguishment costs $ (100) $ - $ - $
- $ - $ - $ - $ - $ (100) $ - Merger-related transaction costs
(66) - -
- -
- - - (66)
- Total $ (166) $
- $ - $ - $ -
$ - $ - $ - $ (166)
$ -
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160204005244/en/
Cigna CorporationWill McDowell, Investor
Relations215-761-4198orMatt Asensio, Media
Relations860-226-2599
Cigna (NYSE:CI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cigna (NYSE:CI)
Historical Stock Chart
From Apr 2023 to Apr 2024